ResMed | RMD - Equity Capital And Reserves



ResMed reported $5.97B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Ansell USD 1.91B 341.4M Jun/2024
AtriCure USD 464.49M 9.87M Jun/2025
Baxter International USD 7.05B 90M Mar/2025
Cochlear AUD 1.87B 27.1M Dec/2024
Cooper Companies USD 8.35B 64.9M Jul/2025
CSL USD 20.55B 3.18B Dec/2024
Dexcom USD 2.57B 306.5M Jun/2025
Edwards Lifesciences USD 10.19B 193.2M Mar/2025
Fisher Paykel Healthcare NZD 1.89B 39.4M Mar/2025
Globus Medical USD 4.3B 207.61M Jun/2025
Haemonetics USD 882.3M 61.46M Jun/2025
Hologic USD 4.84B 223.8M Jun/2025
Idexx Laboratories USD -4410277000 5.86B Jun/2025
Insulet USD 1.46B 132.2M Jun/2025
Integra LifeSciences USD 1.04B 485.48M Jun/2025
Intuitive Surgical USD 17.95B 745.4M Jun/2025
Masimo USD 1.04B 96.4M Jun/2025
Medtronic USD 48.02B 1.36B Apr/2025
Philips EUR 10.38B 1.32B Jun/2025
Ramsay Health Care AUD 4.81B 82.9M Dec/2024
ResMed USD 5.97B 421.73M Jun/2025
Sigma Healthcare AUD 869.95M 817K Jul/2024
Sonic Healthcare AUD 8.2B 120.9M Dec/2024
Steris USD 6.96B 341.24M Jun/2025
Teleflex USD 4.24B 147.7M Jun/2025
Thermo Fisher Scientific USD 49.36B 227M Mar/2025